← Back to Clinical Trials
Recruiting NCT07307417

NCT07307417 Assessment of Respiratory Dysfunction in Obesity and the Use of IMT.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07307417
Status Recruiting
Phase
Sponsor Wroclaw University of Health and Sport Sciences
Condition Obesity & Overweight
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-03-25
Primary Completion 2026-10

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
inspiratory muscle trainingplacebo-IMT

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-03-25 with a primary completion date of 2026-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the project will be to assess the functional condition of the respiratory tract and inflammation resulting from obesity, as well as the possibility of using inspiratory muscle training as a factor reducing the occurrence of dysfunction in the respiratory system.

Eligibility Criteria

Inclusion Criteria: * diagnosed obesity, BMI equal to or greater than 30 kg/m2 * age between 30 and 60 (women and men), * consent of the subject. Exclusion Criteria: * respiratory diseases requiring pharmacological treatment, * acute illness that may affect the training programme: e.g. infection, renal failure, * mental impairment preventing cooperation, * mental disorders preventing contact and cooperation with the patient, * pacemaker, * pregnancy * implanted electronic * medical implants * epilepsy * metal implants.

Contact & Investigator

Central Contact

Paulina Okrzymowska, phD

✉ paulina.okrzymowska@awf.wroc.pl

📞 +48 71 347 3520

Principal Investigator

Dariusz Kałka, prof.

PRINCIPAL INVESTIGATOR

Wroclaw University of Health and Sport Sciences

Frequently Asked Questions

Who can join the NCT07307417 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, up to 60 Years, studying Obesity & Overweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07307417 currently recruiting?

Yes, NCT07307417 is actively recruiting participants. Contact the research team at paulina.okrzymowska@awf.wroc.pl for enrollment information.

Where is the NCT07307417 trial being conducted?

This trial is being conducted at Wroclaw, Poland.

Who is sponsoring the NCT07307417 clinical trial?

NCT07307417 is sponsored by Wroclaw University of Health and Sport Sciences. The principal investigator is Dariusz Kałka, prof. at Wroclaw University of Health and Sport Sciences. The trial plans to enroll 40 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology